<DOC>
	<DOCNO>NCT02580331</DOCNO>
	<brief_summary>Metformin ( MF ) , biguanide group anti-diabetic drug show enhance osteoblast differentiation inhibit osteoclast differentiation vitro , thus may exhibit favourable effect alveolar bone . The present study aim explore efficacy 1 % MF gel local drug delivery system adjunct scale root planing ( SRP ) treatment Class II furcation defect comparison placebo gel .</brief_summary>
	<brief_title>1 % Metformin Gel Treatment Class II Furcation Defects</brief_title>
	<detailed_description>Background : Metformin ( MF ) , biguanide group anti-diabetic drug show enhance osteoblast differentiation inhibit osteoclast differentiation vitro , thus may exhibit favourable effect alveolar bone . The present study aim explore efficacy 1 % MF gel local drug delivery system adjunct scale root planing ( SRP ) treatment Class II furcation defect comparison placebo gel . Methods : Sixty four patient single mandibular buccal class II furcation defect categorize two treatment group : SRP plus 1 % MF ( group 1 ) SRP plus placebo ( group 2 ) . Clinical parameter record baseline , 3 month , 6 month , 9 month , radiographic parameter record baseline , 6 month , 9 month . Defect fill baseline , 6 month , 9 month calculate standardized radiograph use image analysis software .</detailed_description>
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Chronic Periodontitis</mesh_term>
	<mesh_term>Furcation Defects</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>1. presence buccal Class II furcation defect endodontically vital , asymptomatic mandibular first molars radiolucency furcation area intraoral periapical radiograph PD≥ 5 mm horizontal PD≥3 mm follow phase I therapy ( SRP ) patient know systemic disease ; patient know suspected allergy MF ; patient receive systemic MF therapy ; patient aggressive periodontitis ; patient use tobacco form ; patient alcoholism ; patient immunocompromised ; pregnant lactating female .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>